Bluebird Bio (BLUE): This beleaguered gene therapy company awaits two Adcom recommendations. Moderna (MRNA): Moderna awaits official authorization of ...
https://www.google.com/url?rct=j&sa=t&url=https://investorplace.com/2022/06/6-biotech-stocks-june-catalysts/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw1oOZ3wirQ6V5BA-UMYDw1L
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.